Search control section

Fewer than 50 beds
This is a private hospital

The Sydney Clinic

Left hand navigation section

Safety & quality

Healthcare-associated infections

Staphylococcus aureus (S. aureus or ‘Golden staph’) is a type of bacterium that can cause an infection of the bloodstream and can be acquired after a patient receives medical care or treatment in hospital. Contracting an S. aureus bloodstream infection while in hospital can be life-threatening. Hospitals aim to have as few cases as possible.

The data presented below show S. aureus bloodstream infections that were found to have been acquired while receiving care at this hospital.

All healthcare-associated S. aureus bloodstream infections

In 2017–18, the rate of infection was 0.00 cases per 10,000 days of patient care under surveillance.

Year Cases Rate Peer group average Patient days under surveillance
NP† Data were not authorised for publication.
2017–18 NP† 0.00 Not peered NP†
2016–17 NP† 0.00 Not peered NP†
2015–16 NP† 0.00 Not peered NP†
2014–15 NP† 0.00 Not peered NP†
2013–14 NP† 0.00 Not peered NP†
2012–13 NP† 0.00 Not peered NP†
2011–12 NP† 0.00 Not peered NP†
2010–11 NP† 0.00 Not peered NP†

Healthcare-associated methicillin-resistant S. aureus (MRSA) bloodstream infections

An S. aureus bloodstream infection that is identified by a laboratory as being caused by methicillin-resistant S. aureus (MRSA) may cause more harm to patients and is associated with poorer outcomes as there are fewer antibiotics available to treat the infection.

In 2017–18, the rate of infection of MRSA was 0.00 cases per 10,000 days of patient care under surveillance.

Year Cases Rate Peer group average Patient days under surveillance
NP† Data were not authorised for publication.
2017–18 NP† 0.00 Not peered NP†
2016–17 NP† 0.00 Not peered NP†

Healthcare-associated methicillin-sensitive S. aureus (MSSA) bloodstream infections

An S. aureus bloodstream infection that is identified by a laboratory as being caused by methicillin-sensitive S. aureus is referred to as MSSA.

In 2017–18, the rate of infection of MSSA was 0.00 cases per 10,000 days of patient care under surveillance.

Year Cases Rate Peer group average Patient days under surveillance
NP† Data were not authorised for publication.
2017–18 NP† 0.00 Not peered NP†
2016–17 NP† 0.00 Not peered NP†